Ola Myklebost
Position
Emeritus, molecular oncology
Affiliation
- ola.myklebost@uib.no
- Phone number
- +47 90087139
- Visitor address
-
Haukeland universitetssykehus, Laboratoriebygget
5009 Bergen - Postal address
-
P.O. Box 7804NO-5020 BergenNorway
Ola Myklebost
Position
Emeritus, molecular oncology
Affiliation
Research groups
Research
Recently started in Bergen, associated to the Research Group for Precision Oncology, but still supervise projects in my old group at the Norwegian Radium Hospital in Oslo. There we focus on sarcomas, tumours of connective tissues. From Bergen I am leading the two national projects, Norwegian Cancer Genomics Consortium (NCGC) and Norwegian Sarcoma Consortium (NoSarC). My new web page at UiB is at myklebost.uib.no.
Publications
Academic article
- David S. Moura; Jesus Lopez-Marti; Hussein Tawbi et al. (2026). Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma. (external link)
- Toufik Naolou; Nadine Schadzek; Jan Mathis Hornbostel et al. (2025). Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds. (external link)
- Anita Sveen; Bjarne Johannessen; Solveig Margrete Knoph Klokkerud et al. (2024). Evolutionary mode and timing of dissemination of high-grade serous carcinomas. (external link)
- Parmida Ranji; Emma Jonasson; Lisa Andersson et al. (2024). Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development. (external link)
- Yang Zhou; Partho Sarothi Ray; Jianguo Zhu et al. (2024). Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma. (external link)
- Baoyan Bai; Jillian Frances Wise; Daniel Vodak et al. (2024). Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma. (external link)
- Mandy L. Ballinger; Swetansu Pattnaik; Piyushkumar A. Mundra et al. (2023). Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (external link)
- Irantzu Anzar Martinez de Lagran; Brandon Malone; Pubudu Saneth Samarakoon et al. (2023). The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition. (external link)
- Heidi Maria Namløs; Ksenia Khelik; Sigve Nakken et al. (2023). Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. (external link)
- Heidi Maria Namløs; Magne Nordang Skårn; Deeqa Ahmed Mohamed Ali et al. (2022). miR-486-5p expression is regulated by DNA methylation in osteosarcoma. (external link)
- Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2022). Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. (external link)
- Andreas Venizelos; Christina Engebrethsen; Wei Deng et al. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. (external link)
- Anita Sveen; Bjarne Johannessen; Ina Andrassy Eilertsen et al. (2021). The expressed mutational landscape of microsatellite stable colorectal cancers. (external link)
- Iwona Grad; Robert Hanes; Maria del Pilar Ayuda-Duran et al. (2021). Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening. (external link)
- Tatiana Georgiesh; Heidi Maria Namløs; Nitin Sharma et al. (2021). Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour. (external link)
- Marianne Stabell; Thomas Sæther; Åsmund Røhr Kjendseth et al. (2021). Methylation-dependent SUMOylation of the architectural transcription factor HMGA2. (external link)
- Peter Peneder; Adrian M. Stütz; Didier Surdez et al. (2021). Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. (external link)
- Sigve Nakken; Vladislav Saveliev; Oliver Hofmann et al. (2021). Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer. (external link)
- Jillian Wise; Sigve Nakken; Chloe Beate Steen et al. (2020). Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series. (external link)
- Ansastassia Serguienko; Peder Rustøen Braadland; Leonardo A. Meza-Zepeda et al. (2020). Accurate 3-gene-signature for early diagnosis of liposarcoma progression. (external link)
- Constance H. Li; Stephenie D. Prokopec; Ren X. Sun et al. (2020). Sex differences in oncogenic mutational processes. (external link)
- Marc Zapatka; Ivan Borozan; Daniel S. Brewer et al. (2020). The landscape of viral associations in human cancers. (external link)
- Kadir C. Akdemir; Victoria T. Le; Sahaana Chandran et al. (2020). Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. (external link)
- Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2020). Comprehensive molecular characterization of mitochondrial genomes in human cancers. (external link)
- Bernardo Rodriguez-Martin; Eva G. Alvarez; Adrian Baez-Ortega et al. (2020). Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. (external link)
- Matthew H. Bailey; William U. Meyerson; L. Jonathan Dursi et al. (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. (external link)
- Isidro Cortés-Ciriano; Jake June-Koo Lee; Ruibin Xi et al. (2020). Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. (external link)
- of Whole Genomes Consortium ICGC/TCGA Pan-Cancer Analysis; Peter J. Campbell; Gad Getz et al. (2020). Pan-cancer analysis of whole genomes. (external link)
- Yulia Rubanova; Ruian Shi; Caitlin F. Harrigan et al. (2020). Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. (external link)
- Marek Cmero; Ke Yuan; Cheng Soon Ong et al. (2020). Inferring structural variant cancer cell fraction. (external link)
- Marek Cmero; Ke Yuan; Cheng Soon Ong et al. (2020). Inferring structural variant cancer cell fraction. (external link)
- Wei Jiao; Gurnit Atwal; Paz Polak et al. (2020). A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. (external link)
- Lina Sieverling; Chen Hong; Sandra D. Koser et al. (2020). Genomic footprints of activated telomere maintenance mechanisms in cancer. (external link)
- Jessica Dörnen; Ola Myklebost; Thomas Dittmar (2020). Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics. (external link)
- Vinayak Bhandari; Constance H. Li; Robert G. Bristow et al. (2020). Divergent mutational processes distinguish hypoxic and normoxic tumours. (external link)
- Yiqun Zhang; Fengju Chen; Nuno A. Fonseca et al. (2020). High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations. (external link)
- Robert Hanes; Else Munthe; Iwona Grad et al. (2019). Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma. (external link)
- Daniel Vodak; Susanne Lorenz; Sigve Nakken et al. (2018). Sample-Index Misassignment Impacts Tumour Exome Sequencing. (external link)
- Stine Henrichson Kresse; Heidi Maria Namløs; Susanne Lorenz et al. (2018). Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples. (external link)
- Sarina Gouravan; Leonardo Zepeda Meza; Ola Myklebost et al. (2018). Preclinical evaluation of vemurafenib as therapy for BRAFV600E mutated sarcomas. (external link)
- Einar Elvbakken Birkeland; Shan Zhang; Deepak Poduval et al. (2018). Patterns of genomic evolution in advanced melanoma. (external link)
- Heidi Maria Namløs; Kjetil Boye Pedersen; Skyler J. Mishkin et al. (2018). Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. (external link)
- Sigve Nakken; Ghislain Fournous; Daniel Vodak et al. (2018). Personal Cancer Genome Reporter: Variant interpretation report for precision oncology. (external link)
- Marthe Løvf; Sen Zhao; Ulrika Axcrona et al. (2018). Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity. (external link)
- Anastassia Serguienko; Mengyu Wang; Ola Myklebost (2018). Real-time vital mineralization detection and quantification during in vitro osteoblast differentiation. (external link)
- Marie Elise Engkvist; Eva Wessel Stratford; Susanne Lorenz et al. (2017). Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b. (external link)
- Kaja Christine Graue Berg; Peter Andreas Wold Eide; Ina Andrassy Eilertsen et al. (2017). Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. (external link)
- Even Holth Rustad; Eivind Coward; Emilie R Skytøen et al. (2017). Monitoring multiple myeloma by quantification of recurrent mutations in serum. (external link)
- Sam Behjati; Patrick S. Tarpey; Kerstin Haase et al. (2017). Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (external link)
- Heidi Maria Namløs; Olga Zaikova; Bodil Bjerkehagen et al. (2017). Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. (external link)
- Anita Sveen; Bjarne Johannessen; Torstein Tengs et al. (2017). Multilevel genomics of colorectal cancers with microsatellite instability – clinical impact of JAK1 mutations and consensus molecular subtype 1. (external link)
- Åslaug Helland; Odd Terje Brustugun; Sigve Nakken et al. (2017). High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. (external link)
- Anastassia Serguienko; Robert Hanes; Iwona Grad et al. (2017). PP2A regulatory subunit b55γ is a gatekeeper of osteoblast maturation and lineage maintenance. (external link)
- Tale Barøy; Chandra Sekhar Reddy Chilamakuri; Susanne Lorenz et al. (2016). Genome analysis of osteosarcoma progression samples identifies FGFR1 overexpression as a potential treatment target and CHM as a candidate tumor suppressor gene. (external link)
- Vandana Sandhu; David C. Wedge; Inger Marie Bowitz Lothe et al. (2016). The genomic landscape of pancreatic and periampullary adenocarcinoma. (external link)
- Robert Hanes; Iwona Grad; Susanne Lorenz et al. (2016). Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. (external link)
- Susanne Lorenz; Tale Barøy; Jinchang Sun et al. (2016). Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. (external link)
- Ann Rita Halvorsen; Laxmi Silwal-Pandit; Leonardo Zepeda Meza et al. (2016). TP53 mutation spectrum in smokers and never smoking lung cancer patients. (external link)
- Mandy L. Ballinger; David L. Goode; Isabelle Ray-Coquard et al. (2016). Monogenic and polygenic determinants of sarcoma risk: an international genetic study. (external link)
- Elin Hallan Naderi; Seham Skah; Hege Katrin Ugland et al. (2015). Bone marrow stroma-derived PGE<sub>2</sub> protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death. (external link)
- Anastassia Serguienko; Iwona Grad; Anna Wennerstrøm et al. (2015). Metabolic reprogramming of metastatic breast cancer and melanoma by Let-7a microRNA. (external link)
- S Safavi; S Järnum; C Vannas et al. (2015). HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo. (external link)
- Ola Myklebost (2015). Norwegian Cancer Genomics Consortium: A platform for research on personalized cancer medicine in a public health system. (external link)
- Even Holth Rustad; Hong Yan Dai; Håkon Hov et al. (2015). BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis. (external link)
- Deepika Kanojia; Yasunobu Nagata; Manoj Garg et al. (2015). Genomic landscape of liposarcoma. (external link)
- Y.S Ju; J.M.C Tubio; W Mifsud et al. (2015). Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. (external link)
- Magne Nordang Skårn; Paul Noordhuis; Mengyu Wang et al. (2014). Generation and characterization of an immortalized human mesenchymal stromal cell line. (external link)
- Anna Wennerstrøm; Inger Marie Bowitz Lothe; Vandana Sandhu et al. (2014). Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines. (external link)
- Jakob K. Anninga; Anne-Marie Cleton-Jansen; Bass Hassan et al. (2014). Workshop Report on the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting: Integration of Clinical Trials with Tumour Biology.. (external link)
- JMC Tubio; Y Li; YS Ju et al. (2014). Extensive transduction of non-reptitive DNA mediated by L1 retrotransposition in cancer genomes. (external link)
- Eva Wessel Stratford; Jeanette L. Daffinrud; Else Munthe et al. (2014). The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. (external link)
- Anne-Mari Håkelien; Jan Christian Bryne; Kristine Gjul Harstad et al. (2014). The regulatory landscape of osteogenic differentiation. (external link)
- Chandra Sekhar Reddy Chilamakuri; Susanne Lorenz; Mohammed-Amin Madoui et al. (2014). Performance comparison of four exome capture systems for deep sequencing. (external link)
- Tale Barøy; Stine Henrichson Kresse; Magne Nordang Skårn et al. (2014). Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model. (external link)
- Eva Wessel Stratford; Ola Myklebost (2014). TRAP1 is a novel interaction partner of PML, localised with PML in nuclear bodies and relocating with PML to the cytoplasm following stress. (external link)
- Dale W. Garsed; Owen J. Marshall; Vincent D.A. Corbin et al. (2014). The Architecture and Evolution of Cancer Neochromosomes. (external link)
- Laurence Bianchini; Loic Birtwisle; Esma Saada et al. (2013). Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas. (external link)
- Marieke L. Kuijjer; Elisabeth FP Peterse; BEWM van den Akker et al. (2013). IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma. (external link)
- Eva Wessel Stratford; Monica Bostad; Castro Russell et al. (2013). Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity. (external link)
- Cecilie Sandberg; Gabriel Altschuler; Jieun Jeong et al. (2013). Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. (external link)
- Magne Skårn; Tale Barøy; Eva Wessel Stratford et al. (2013). Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells. (external link)
- Hege Oma Ohnstad; Russell Castro; Jinchang Sun et al. (2013). Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma. (external link)
- Joyce Doorn; Hugo A.M. Fernandes; Bach Q. Le et al. (2013). A small molecule approach to engineering vascularized tissue. (external link)
- Silje Anett Ugland Lauvrak; Else Munthe; Stine Henrichson Kresse et al. (2013). Functional characterization of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. (external link)
- Torfinn Nome; Gard O Sundby Thomassen; Jarle Bruun et al. (2013). Common fusion transcripts identified in colorectal cancer cell lines by high throughput RNA sequencing. (external link)
- Sam Behjati; Patrick S. Tarpey; Nadège Presneau et al. (2013). Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. (external link)
- Stine Henrichson Kresse; Leonardo Zepeda Meza; Isidro Machado et al. (2012). Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations. (external link)
- Stine Henrichson Kresse; Halfdan Rydbeck; Magne Skårn et al. (2012). Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma. (external link)
- Heidi Maria Namløs; Stine Henrichson Kresse; Christoph Rainer Muller et al. (2012). Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. (external link)
- Marieke L. Kuijjer; Halfdan Rydbeck; Stine Henrichson Kresse et al. (2012). Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. (external link)
- Magne Skårn; Heidi Maria Namløs; Paul Noordhuis et al. (2012). Adipocyte Differentiation of Human Bone Marrow-Derived Stromal Cells Is Modulated by MicroRNA-155, MicroRNA-221, and MicroRNA-222. (external link)
- Heidi Maria Namløs; Leonardo Andrés Meza-Zepeda; Tale Barøy et al. (2012). Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs. (external link)
- Eva Wessel Stratford; Russell Castro; Jeanette L. Daffinrud et al. (2012). Characterization of liposarcoma cell lines for preclinical and biological studies. (external link)
- Hege Oma Ohnstad; Erik Braarød Paulsen; Paul Noordhuis et al. (2011). MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines. (external link)
- Geir Olav Hjortland; Leonardo Zepeda Meza; Klaus Beiske et al. (2011). Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. (external link)
- Marieke L. Kuijjer; Heidi Maria Namløs; Esther I. Hauben et al. (2011). mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. (external link)
- Emilie P. Buddingh; Marieke L. Kuijjer; Ronald A.J. Duim et al. (2011). Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents. (external link)
- Magne Skårn; Heidi Maria Namløs; Paul Noordhuis et al. (2011). Adipocyte Differentiation of Immortalized Human Bone Marrow-Derived Stromal Cells is Modulated by microRNA-155, microRNA-221 and microRNA-222. (external link)
- Eva Wessel Stratford; R Castro; Anna Berit Wennerström et al. (2011). Combined ALDH and CD133 expression defines a stem-like cancer cell population in liposarcoma xenograft. (external link)
- Stine Henrichson Kresse; Leonardo Zepeda Meza; Isidro Machado et al. (2011). Genomic validation of preclinical xenograft models of human sarcoma reveals recurrent loss of aberrations. (external link)
- EP Buddingh; ML Kuijjer; RL Duim et al. (2011). Metastasis suppression by tumor-infiltrating macrophages in high-grade osteosarcoma. (external link)
- Ellen Tenstad; Anna Tourovskaia; Albert Folch et al. (2010). Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device. (external link)
- Marianne Brodtkorb Eide; Knut Liestøl; Ole Christian Lingjærde et al. (2010). Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. (external link)
- E Mayordomo; I Machado; F Giner et al. (2010). A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models. (external link)
- Stine Henrichson Kresse; K Szuhai; Ana Heslanyeth Barragan Polania et al. (2010). Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. (external link)
- Stine Henrichson Kresse; Hege Oma Ohnstad; Bodil Bjerkehagen et al. (2010). DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation. (external link)
- Christoph Rainer Muller; Heidi Maria Namløs; Johan Bjerner et al. (2010). Characterization of Treatment Response to Recombinant Interferon-α2b in Osteosarcoma Xenografts. (external link)
- L Ottaviano; K-L Schaefer; M Gajewski et al. (2010). Molecular Characterization of Commonly Used Cell Lines for Bone Tumor Research: A Trans-European EuroBoNet Effort. (external link)
- Jørn Henriksen; Marianne Stabell; Leonardo Zepeda Meza et al. (2010). Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells. (external link)
- Gustav Lehne; Unn-Hilde Grasmo-Wendler; Jeanne-Marie Berner et al. (2009). Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. (external link)
- L Ottaviano; K-L Schaefer; M Gajewski et al. (2009). Molecular characterization of commonly used cell lines for bone tumor research. A trans-European EuroBoNet effort. (external link)
- Stine Henrichson Kresse; HO Ohnstad; Erik Braarød Paulsen et al. (2009). LSAMP, a Novel Candidate Tumor Suppressor Gene in Human Osteosarcomas, Identified by Array Comparative Genomic Hybridization. (external link)
- Stine Henrichson Kresse; Magne Skårn; Hege Oma Ohnstad et al. (2008). DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. (external link)
- Eric Roman; Leonardo A. Meza-Zepeda; Stine H. Kresse et al. (2008). Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. (external link)
- Zepeda Leonardo Meza; Agate Noer; John Arne Dahl et al. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. (external link)
- E Roman; Leonardo Andres Zepeda Meza; Stine Henrichson Kresse et al. (2008). Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. (external link)
- H Lyng; M Lando; RS Brovig et al. (2008). GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data. (external link)
- Kristine Kleivi; Guro E Lind; Chieu B Diep et al. (2007). Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. (external link)
- CR Muller; EB Paulsen; P Noordhuis et al. (2007). Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A. (external link)
- P Francis; HM Namlos; C Muller et al. (2007). Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. (external link)
- Jeanne-Marie Berner; Christoph Rainer Muller; Marit Holden et al. (2006). Sampling effects on gene expression data from a human tumour xenograft. (external link)
Academic literature review
- Leo Kager; Jeremy Whelan; U Dirksen et al. (2016). The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. (external link)
- Ola Myklebost (2015). Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls. (external link)
- José M.C. Tubio; Yilong Li; Young Seok Ju et al. (2014). Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. (external link)
- DM Thomas; M Wilhelm; Anne-Marie Cleton-Jansen et al. (2012). Workshop report on the European Bone Sarcoma Networking Meeting: integration of clinical trials with tumor biology. (external link)
Conference abstract
- Baoyan Bai; Daniel Vodák; Sigve Nakken et al. (2019). Deep profiling of genetic aberrations and clonal evolution in follicular lymphoma. (external link)
- Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2018). Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse. (external link)
- Rolf Inge Skotheim; Torfinn Nome; Gard O Sundby Thomassen et al. (2012). Identification of Fusion Transcripts in Colorectal Cancer by Combined RNA-seq and Exon Microarray Analyses. (external link)
- Heidi Maria Namløs; Stine Henrichson Kresse; Ingrid Helene Garmann Østensen et al. (2010). Integrated analysis reveals overexpression of miRNA clusters in osteosarcomas. (external link)
- Stine Henrichson Kresse; Halfdan Rydbeck; Ana Heslanyeth Barragan Polania et al. (2010). Integrative analysis of genome-wide genetic and epigenetic changes in human osteosarcomas. (external link)
- T Baroy; Dahlia Hopmeier; Stine Henrichson Kresse et al. (2010). Characterisation of LSAMP, a novel candidate tumour suppressor gene in osteosarcomas. (external link)
Conference lecture
- Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2018). Clonal Evolution of Multiple Myeloma After Treatment with Novel Agents. (external link)
- Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2017). Detection of mutations in Multiple Myeloma during different stages of disease. (external link)
- Ola Myklebost (2017). Sarcomas: Genomic Landscape and potential targets.. (external link)
- Ola Myklebost (2012). Personalized cancer medicine. (external link)
Conference poster
- Kristine Misund; Davine Hofste op Bruinink; Eivind Coward et al. (2018). Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse. (external link)
- Eivind Coward; Kristine Misund; Davine Hofste op Bruinink et al. (2017). Exome sequencing of multiple myeloma at sequential time points. (external link)
- Marianne Stabell; Åshild Skarshaug Breivik; Ola Myklebost (2010). Lysine methylation of HMGA2 by the monomethyltransferase Set7/9. (external link)
Doctoral thesis (PhD)
- Robert Hanes; Ola Myklebost; Leonardo A Meza-Zepeda et al. (2018). Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma. (external link)
- Isabelle Budin Ljøsne; Jan Helge Solbakk; Jennifer Ruth Harris et al. (2018). Bringing personalized medicine to people. (external link)
- Stine Henrichson Kresse; Ola Myklebost (2008). Chromosomal aberrations in human sarcomas identified using genomic microarrays. (external link)
Journal corrigendum
- Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2023). Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x). (external link)
- Esther Rheinbay; Morten Muhlig Nielsen; Federico Abascal et al. (2023). Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (Nature, (2020), 578, 7793, (102-111), 10.1038/s41586-020-1965-x). (external link)
- Marc Zapatka; Ivan Borozan; Daniel S. Brewer et al. (2023). Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9). (external link)
- Claudia Calabrese; Natalie R. Davidson; Deniz Demircioğlu et al. (2023). Author Correction: Genomic basis for RNA alterations in cancer (Nature, (2020), 578, 7793, (129-136), 10.1038/s41586-020-1970-0). (external link)
- Sergei Yakneen; Sebastian Martin Waszak; Brice Aminou et al. (2023). Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3). (external link)
- Kadir C. Akdemir; Victoria T. Le; Sahaana Chandran et al. (2023). Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y). (external link)
- Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2023). Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x). (external link)
- Isidro Cortés-Ciriano; Jake June-Koo Lee; Ruibin Xi et al. (2023). Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7). (external link)
- Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner et al. (2023). Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7). (external link)
- Yilong Li; Nicola D. Roberts; Jeremiah A. Wala et al. (2023). Author Correction: Patterns of somatic structural variation in human cancer genomes (Nature, (2020), 578, 7793, (112-121), 10.1038/s41586-019-1913-9). (external link)
- Ludmil B. Alexandrov; Jaegil Kim; Nicholas J. Haradhvala et al. (2023). Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3). (external link)
- Lauri A. Aaltonen; Federico Abascal; Adam Abeshouse et al. (2023). Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6). (external link)
- Yuan Yuan; Young Seok Ju; Youngwook Kim et al. (2023). Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x). (external link)
- Bernardo Rodriguez-Martin; Eva G. Alvarez; Adrian Baez-Ortega et al. (2023). Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (Nature Genetics, (2020), 52, 3, (306-319), 10.1038/s41588-019-0562-0). (external link)
- Shimin Shuai; Federico Abascal; Samirkumar B. Amin et al. (2022). Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1). (external link)
- Marek Cmero; Ke Yuan; Cheng Soon Ong et al. (2022). Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8). (external link)
- Yiqun Zhang; Fengju Chen; Nuno A. Fonseca et al. (2022). Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w). (external link)
- Marta Paczkowska; Jonathan Barenboim; Nardnisa Sintupisut et al. (2022). Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9). (external link)
- Wei Jiao; Gurnit Atwal; Paz Polak et al. (2022). Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8). (external link)
- Matthew A. Reyna; David Haan; Marta Paczkowska et al. (2022). Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0). (external link)
- Yulia Rubanova; Ruian Shi; Caitlin F. Harrigan et al. (2022). Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7). (external link)
- Vinayak Bhandari; Constance H. Li; Robert G. Bristow et al. (2022). Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x). (external link)
- Lina Sieverling; Chen Hong; Sandra D. Koser et al. (2022). Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9). (external link)
Letter to the editor
Media feature article
- Steinar Aamdal; Heidi Beate Bentzen; Ole Johan Borge et al. (2017). Åpne Nordens grenser for forskning og behandling. (external link)
- Ola Myklebost; Ragnhild A Lothe; Bjørn Tore Gjertsen et al. (2015). Bør hver kreftpasient bli et eget forskningsprosjekt?. (external link)
- Rolf Inge Skotheim; Leonardo Andrés Meza-Zepeda; Eivind Hovig et al. (2012). Genomsekvensering for persontilpasset kreftbehandling. (external link)
Media interview
- Eva Wessel Stratford; Ola Myklebost (2016). Vil behandle sjeldne kreftformer med personlig medisinering. (external link)
- Ola Myklebost (2015). “Helseforetakene driver beskyttede industribedrifter” Om svak satsing på fagutvikling og utprøvende behandling.. (external link)
- Ola Myklebost (2015). Ny studie: Flaks eller uflaks bestemmer oftest om du får kreft – ikke usunn livsstil.Tilfeldige mutasjoner i DNA står bak to av tre krefttilfeller.. (external link)
- Ola Myklebost (2015). ”It’s All About the Genome”. (external link)
- Ola Myklebost (2015). ”Jakten på en kreftkur”. (external link)
- Ola Myklebost (2014). Muligheter med livets strekkkode. (external link)
- Ola Myklebost (2014). "Dødstest" kan forusi risiko for å dø i løpet av fem år. (external link)
- Ola Myklebost (2014). En ny generasjon kreftmedisin. (external link)
- Ola Myklebost (2013). Storsatsing på bedre kreftbehandling. (external link)
- Ola Myklebost (2013). Beregner seg frem til ny kreftbehandling. (external link)
- Ola Myklebost (2013). Kreftforskning; Kan kampen vinnes?. (external link)
- Ola Myklebost (2013). Kartlegger kreftgenene. (external link)
- Ola Myklebost (2012). Norway invests in personalized cancer care. (external link)
- Ola Myklebost (2012). Når gener skrus av og på. (external link)
- Ola Myklebost; Ragnhild A. Lothe (2012). Persontilpasset kreftbehandling. (external link)
- Ola Myklebost (2012). Intervju om medisinske gjennombrudd. (external link)
- Ola Myklebost (2012). Persontilpasset kreftmedisin. (external link)
- Ola Myklebost (2012). Om Norsk Kreftgenomikkonsortium. (external link)
- Ola Myklebost (2012). På vei mot persontilpasset kreftmedisin. (external link)
- Ola Myklebost (2012). Norway to bring cancer tests to the clinic. (external link)
- Ola Myklebost (2012). Reading cancer's blueprint. (external link)
- Ola Myklebost (2012). Skal kartleggja kreftgenar hos 4000 nordmenn. (external link)
- Ola Myklebost (2012). Intervju om persontilpasset kreftmedisin. (external link)
- Ola Myklebost (2009). “Utforsker kreftsynder” Artikkel om symposiet “Frontiers in Cancer Stem Cell Research: From Basic Science Towards a Cure”. (external link)
- Ola Myklebost; Leonardo Andres Zepeda Meza (2009). Skal lage “bok” over alle krefttyper. (external link)
- Ola Myklebost (2009). Dreper vi de riktige kreftcellene?. (external link)